Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Ambrisentan plus spironolactone
(D00443)		1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2Spironolactone
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬7件: 46, 58, 67, 86, 113, 210, 225 💬
3Spironolactone and conivaptan
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 86 💬
4Spironolactone mylan 25 MG comprimé pelliculé Sécable
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 46 💬
5Spironolactone or finerenone
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 218 💬